Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy (Q34618277)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy |
scientific article |
Statements
1 reference
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy (English)
1 reference
Carsten Bokemeyer
1 reference
Diane Seimetz
1 reference
Horst Lindhofer
1 reference
27 March 2010
1 reference
1 reference
36
1 reference
6
1 reference
458-467
1 reference
Identifiers
1 reference
1 reference